Table of Contents

Managing type 2 diabetes has evolved with new medications, offering more options to control blood sugar and address other health concerns. While Ozempic, a popular injectable, is widely recognized for its ability to manage glucose and support weight loss, did you know that the same active ingredient, Semaglutide, is available as a pill with Rybelsus? This gives people the choice to avoid injections and still get effective treatment.

In this article, you will learn about the key differences and similarities between Rybelsus (oral semaglutide) and Ozempic (injectable semaglutide), two forms of the same active ingredient, and how they compare regarding effectiveness, dosage, side effects, and cost.

Key Takeaways

  • Both Rybelsus and Ozempic contain the active ingredient Semaglutide, but Rybelsus is taken daily as a pill, while Ozempic is a weekly injection.
  • Studies show that Ozempic can lower HbA1c levels by up to 1.8%, while Rybelsus can lower HbA1c by about 1.4%, making it slightly more effective for blood sugar control.
  • Ozempic leads to more significant weight loss, with users losing 14.9% of their body weight, compared to less than 5% for Rybelsus.
  • You cannot take Rybelsus and Ozempic together, as both contain Semaglutide and combining them can cause an overdose.
  • Without insurance, Rybelsus costs around $900 per month in the U.S., while Ozempic can cost up to $1,000. Still, international sources like BuyCanadianInsulin.com offer lower prices—$297 for 30 Rybelsus tablets and $329.95 for one Ozempic pen.
  • Both medications can cause side effects like nausea, diarrhea, and weight loss, but Ozempic users may also experience dizziness, fatigue, and injection site reactions, while Rybelsus may increase heart rate.

Rybelsus vs Ozempic

Key Components Rybelsus Ozempic
Brand Names Rybelsus Ozempic
Is a Generic Available? No No
What Forms Does it Come In? Oral tablets Injection (prefilled pen)
Typical Dosages 3 mg, 7 mg, 14 mg tablets 0.25 mg, 0.5 mg, 1 mg injection
Who Is Approved to Take It? Adults with Type 2 diabetes Adults with Type 2 diabetes
How Often Is It Taken? Once daily Once weekly
Common Side Effects Nausea, diarrhea, vomiting Nausea, diarrhea, dizziness
FDA Approval Status Approved for Type 2 diabetes Approved for Type 2 diabetes

What Is Rybelsus vs Ozempic?

Rybelsus and Ozempic are both medications used to manage type 2 diabetes. They work by lowering blood sugar levels and helping to improve insulin sensitivity. The primary difference between them lies in their form. Rybelsus is an oral medication, making it an attractive option for patients who prefer to avoid injections. 

Ozempic, on the other hand, is administered via injection once a week. Despite the difference in administration, both medications have the same active ingredient, semaglutide, which is responsible for their similar effects on blood sugar control.

How Does Rybelsus vs Ozempic Work?

Both Rybelsus and Ozempic work by targeting a hormone in the body called GLP-1 (glucagon-like peptide-1). GLP-1 helps regulate blood sugar by stimulating insulin release when glucose levels are high, reducing the amount of sugar the liver produces, and slowing down digestion, which helps keep blood sugar levels stable after meals.

The active ingredient in both medications, Semaglutide, mimics the action of GLP-1. However, the difference between the two lies in how they are delivered into the body. Ozempic is an injectable medication that bypasses the digestive system and enters the bloodstream more directly. Rybelsus, an oral tablet, must pass through the digestive system before being absorbed, which can slightly affect how much of the drug is available in the bloodstream compared to the injectable form.

Though both medications work similarly, the oral version of Rybelsus may require higher doses to achieve the same blood levels as Ozempic since part of the medication is broken down in the digestive tract before it can be absorbed.

Rybelsus vs Ozempic Efficacy

Both Rybelsus and Ozempic have proven effective in controlling blood sugar levels and assisting with weight loss in patients with type 2 diabetes. However, their effectiveness can vary depending on how they are administered and the individual patient’s response.

Rybelsus vs Ozempic for Diabetes

When comparing the efficacy of Rybelsus and Ozempic for managing type 2 diabetes, studies show that both medications significantly reduce HbA1c levels. However, Ozempic tends to have a slightly greater impact on blood glucose control due to its higher bioavailability through injection. For example, in a clinical trial, patients using Ozempic saw an average reduction in HbA1c of up to 1.8%, while those using Rybelsus experienced an average reduction of about 1.0-1.4%.

User experience also reflects these results, with many patients finding that Ozempic provides more consistent control over blood sugar levels due to weekly injections, which deliver a steady amount of Semaglutide throughout the week.

Rybelsus vs Ozempic for Weight Loss

Weight loss significantly benefits many type 2 diabetes patients using these medications. Rybelsus and Ozempic have been shown to help patients lose weight, but once again, Ozempic typically produces more pronounced results. In a clinical study, patients using Ozempic lost an average of 14.9% of their body weight over 68 weeks, while those taking Rybelsus lost less than 5%.

The difference in weight loss efficacy is likely due to the differences in how the medication is absorbed. Ozempic’s injectable form ensures a more consistent dose, whereas Rybelsus may not be absorbed as efficiently through the digestive system, leading to less Semaglutide reaching the bloodstream.

Rybelsus vs Ozempic Dosage

Both Rybelsus and Ozempic have structured dosing schedules designed to gradually increase the amount of Semaglutide to allow the body to adjust and minimize side effects.  Let’s look at the specifics in the table below:

Aspect Rybelsus Ozempic
Form Oral tablet Injectable (once weekly)
Starting Dose 3 mg once daily for 30 days 0.25 mg once a week for 4 weeks
Dose Increase Increase to 7 mg once daily after 30 days Increase to 0.5 mg after 4 weeks
Maximum Dose 14 mg once daily Up to 1 mg or 2 mg once weekly, depending on the treatment goal
Timing of Administration Take on an empty stomach at least 30 minutes before food or drink Once a week, same day each week

The initial doses of both medications start low to help the body adapt, and then they are gradually increased. The maximum dosage of Ozempic can go up to 2 mg weekly, while Rybelsus reaches its highest effective dose at 14 mg daily. Timing also plays a role—Rybelsus must be taken on an empty stomach to ensure absorption, whereas Ozempic’s weekly injection offers more convenience in terms of administration.

Rybelsus vs Ozempic Side Effects

Both Rybelsus and Ozempic can cause various side effects, from mild to serious. Below is a breakdown of common and serious side effects reported with both medications:

Mild Side Effects

  • Abdominal pain
  • Burping
  • Constipation
  • Diarrhea
  • Flatulence (gas)
  • Gastroesophageal reflux disease (GERD)
  • Indigestion (upset stomach)
  • Nausea and vomiting
  • Weight loss
  • Changes in taste (Ozempic only)
  • Dizziness (Ozempic only)
  • Fatigue (Ozempic only)
  • Increased heart rate (Rybelsus only)
  • Loss of appetite (Rybelsus only)
  • Injection site reactions (Ozempic only)

Serious Side Effects

  • Hypoglycemia (low blood sugar)
  • Gallstones or cholecystitis (swelling of the gallbladder)
  • Pancreatitis (swelling of the pancreas)
  • Severe digestive problems (such as severe diarrhea leading to dehydration or kidney issues)
  • Diabetic retinopathy (damage to blood vessels in the eye)
  • Risk of thyroid cancer
  • Allergic reactions

Though both medications share these side effects, the injectable form (Ozempic) may lead to more consistent drug absorption, potentially influencing the severity or frequency of side effects compared to the oral form (Rybelsus).

What Are the Warnings for Rybelsus and Ozempic?

Due to certain medical conditions or risk factors, Rybelsus and Ozempic may not be appropriate for everyone. These drugs carry specific warnings that are crucial to discuss with your doctor before starting treatment.

Boxed Warning: Risk of Thyroid Cancer

Both Rybelsus and Ozempic come with a boxed warning for the potential risk of thyroid cancer. This is the most serious warning issued by the FDA, alerting patients and doctors to possible dangerous effects. In animal studies, the active ingredient in both medications, Semaglutide, was linked to an increased risk of thyroid tumors. Although these results are from animal studies, and it’s unclear if they apply to humans, caution is advised.

Doctors will typically avoid prescribing Rybelsus or Ozempic to individuals with the following risk factors:

  • Family or personal history of medullary thyroid cancer (a rare type of thyroid cancer)
  • Multiple endocrine neoplasia type 2 (MEN2), a genetic condition that increases the risk of thyroid cancer

Symptoms of thyroid cancer include:

  • A lump in the neck
  • Hoarseness
  • Difficulty swallowing

If you notice any of these symptoms while using either drug, contact your doctor immediately for further evaluation.

Other Warnings

In addition to the boxed warning, both medications have other important warnings to be aware of:

If you’ve had an allergic reaction to Semaglutide or any of the ingredients in Rybelsus or Ozempic

  • If you are pregnant or planning to become pregnant
  • If you are breastfeeding or planning to breastfeed
  • If you have a history of pancreas problems (such as pancreatitis)
  • If you have kidney issues
  • If you have diabetic retinopathy (a complication affecting the eyes)

Rybelsus vs Ozempic Cost

The cost of Rybelsus and Ozempic can be a significant consideration for many patients, and prices can vary widely based on factors like insurance, location, and pharmacy choices.

With Insurance

If covered by insurance, the out-of-pocket cost for Rybelsus and Ozempic can be as low as $25 to $100 per month, depending on the plan. However, some insurance plans may require prior authorization or may not cover the full cost of these medications.

Without Insurance

Without insurance, the prices are notably higher. In the US, Rybelsus typically costs around $900 monthly for a 30-day supply, while Ozempic averages between $950 and $1,000 monthly for the 1 mg dose. These high costs can be a financial burden, especially for those requiring long-term treatment.

International Pricing

For patients looking to reduce costs, international sources such as BuyCanadianInsulin.com offer significant savings. For instance, Rybelsus is available for $297, and Ozempic can be purchased for as low as $329.95. This presents a more affordable option for those without sufficient insurance coverage or seeking to lower their medication expenses. Here’s a detailed breakdown of their costs in the US compared to international sources:

Medication Quantity US Price BCI Price
Rybelsus (3 mg) 30 tablets $900 $297
60 tablets $1,800 $570
90 tablets $2,700 $810
Rybelsus (7 mg) 30 tablets $900 $305
60 tablets $1,800 $580
90 tablets $2,700 $855
Rybelsus (14 mg) 30 tablets $900 $315
60 tablets $1,800 $610
90 tablets $2,700 $900
Ozempic (2 mg/3mL) 1 pen $1,203 $329.95
2 pens $2,406 $650.00
3 pens $3,609 $969.00
4 pens $4,812 $1,276.00
Ozempic (4 mg/3mL) 1 pen $1,203 $329.95
2 pens $2,406 $650.00
3 pens $3,609 $969.00
4 pens $4,812 $1,276.00

Can I Switch Between Rybelsus and Ozempic?

Yes, it is possible to switch between Rybelsus and Ozempic, but this should only be done under the guidance of a doctor. The switch may involve adjusting dosages, as Rybelsus is taken daily in pill form, and Ozempic is administered weekly as an injection. Your doctor will decide the best timing and dosage to ensure the transition is smooth and effective in controlling your blood sugar levels.

What Should I Ask My Doctor?

When considering either Rybelsus or Ozempic, having an open conversation with your doctor is important. Here are some questions you might ask:

  • Which medication will work best for managing my type 2 diabetes?
  • What are the potential risks for me, given my medical history?
  • How will switching between Rybelsus and Ozempic affect my diabetes management?
  • How can I manage the side effects of these medications?
  • Are there alternative medications if Rybelsus or Ozempic isn’t suitable for me?
  • What are the cost differences between the two options, and how can I reduce my out-of-pocket expenses?

Conclusion: Which One Should You Choose?

Choosing between Rybelsus and Ozempic depends on your personal preferences, lifestyle, and medical needs. If you prefer the convenience of taking a pill daily, Rybelsus might be a better fit. On the other hand, if you’re comfortable with weekly injections and want slightly more consistent blood sugar control and potential weight loss, Ozempic could be the better option.

It’s important to discuss both medications with your doctor to determine which one aligns best with your health goals, risk factors, and potential side effects. Ultimately, the decision should be based on what will work best for your diabetes management, considering both your medical history and lifestyle.

Frequently Asked Questions

Rybelsus and Ozempic are primarily approved for managing type 2 diabetes, but Ozempic is sometimes prescribed “off-label” for weight loss in people without diabetes. While Rybelsus is not typically used for this purpose, studies have shown that both medications can help lose weight. However, only Wegovy, another form of Semaglutide, is FDA-approved specifically for weight loss in non-diabetic individuals.
Rybelsus and Ozempic start to work within a few weeks, but it may take several months to see full effects on blood sugar levels and weight loss.
If you miss a dose of Rybelsus, take it as soon as you remember, but don’t double the dose. For Ozempic, if you miss a weekly dose, take it within 5 days; otherwise, skip the missed dose and resume your normal schedule.
Yes, both medications can be combined with other diabetes treatments, such as metformin, to improve blood sugar control. However, dosing adjustments may be needed to prevent low blood sugar.
No, Rybelsus and Ozempic are not approved for type 1 diabetes. They are specifically designed for managing type 2 diabetes.
It is not recommended to stop either medication suddenly, as this can rapidly increase blood sugar levels. If you need to stop, following a gradual discontinuation plan is important.
While both medications are generally safe for most people with kidney issues, they can lead to dehydration in some cases, which may impact kidney function, especially if you experience vomiting or diarrhea.
Rybelsus tablets should be stored at room temperature, while Ozempic pens should be refrigerated before use. Once in use, Ozempic pens can be stored at room temperature for up to 56 days.
Yes, switching between the two medications is possible, but dosage adjustments will be necessary to ensure the same level of blood sugar control.
No, you should not take Rybelsus and Ozempic together since they contain the same active ingredient, Semaglutide. Using both can lead to an overdose or unwanted side effects.
Both medications can interact with other drugs, especially those that affect blood sugar levels, like insulin or sulfonylureas, which can increase the risk of low blood sugar.
Yes, both medications are designed for long-term use to help manage type 2 diabetes and its associated risks, as long as they continue to work for you and do not cause intolerable side effects.

Sources

Berra, C. C., Rossi, M. C., Mirani, M., Ceccarelli, D. C., Romano, C., Sassi, L., Peretti, E., Favacchio, G., Pastore, I., Folini, L., Graziano, G., Lunati, M. E., Solerte, S. B., & Fiorina, P. (2023). Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01). Journal of Diabetes Research and Clinical Practice, PMC9889982. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889982/

U.S. Food and Drug Administration. (2024). Ozempic (semaglutide) injection label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213051s018lbl.pdf

U.S. Food and Drug Administration. (2023). Rybelsus (semaglutide) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf